InvestorsHub Logo
Followers 119
Posts 77595
Boards Moderated 4
Alias Born 05/26/2004

Re: None

Thursday, 03/05/2015 10:46:22 AM

Thursday, March 05, 2015 10:46:22 AM

Post# of 704570
FDA has awarded Catalyst Pharmaceuticals $CPRX orphan drug designation for Firdapse in treatment of congenital myasthenic syndromes

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.